Robert Williams, Jr. Sells 1,000,000 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Robert Williams, Jr. sold 1,000,000 shares of Aveanna Healthcare stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $8.00, for a total value of $8,000,000.00. Following the transaction, the insider owned 245,251 shares of the company’s stock, valued at $1,962,008. This represents a 80.31% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Aveanna Healthcare Price Performance

AVAH stock opened at $8.64 on Friday. The stock’s 50 day moving average price is $7.14 and its 200 day moving average price is $7.58. The firm has a market cap of $1.88 billion, a P/E ratio of 7.32, a PEG ratio of 0.89 and a beta of 1.93. The company has a debt-to-equity ratio of 5.35, a quick ratio of 1.47 and a current ratio of 1.47. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.73 and a 1 year high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. The company had revenue of $647.91 million during the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.Aveanna Healthcare’s revenue for the quarter was up 15.9% on a year-over-year basis. On average, sell-side analysts expect that Aveanna Healthcare Holdings Inc. will post 0.65 earnings per share for the current fiscal year.

Institutional Trading of Aveanna Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd raised its position in shares of Aveanna Healthcare by 252.4% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after acquiring an additional 2,400 shares in the last quarter. Quantbot Technologies LP acquired a new stake in Aveanna Healthcare during the second quarter worth about $43,000. Summit Securities Group LLC bought a new position in Aveanna Healthcare in the first quarter worth about $53,000. Oxford Asset Management LLP bought a new position in Aveanna Healthcare in the second quarter worth about $64,000. Finally, Bayesian Capital Management LP acquired a new position in Aveanna Healthcare in the second quarter valued at approximately $85,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on AVAH. Stephens upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $10.00 to $11.00 in a report on Friday, May 15th. Barclays decreased their target price on Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a report on Monday, May 18th. Raymond James Financial raised shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 target price for the company in a research report on Friday, March 20th. BMO Capital Markets reduced their price target on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 20th. Finally, Royal Bank Of Canada upgraded shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective for the company in a research note on Wednesday, June 3rd. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $10.50.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.